A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing ...

One parent skipped the marketing buzz and let a toddler decide which of this year's top Christmas toys actually hold a ...

Eli Lilly is in advanced talks to acquire Ventyx Biosciences, which is developing pills for autoimmune conditions, for more ...

Market Report by Application, Distribution Channel, Route of Administration and Company Analysis, 2025-2033" has been added ...

A patient enrolled in a long-term study of Pfizer's hemophilia drug Hympavzi died after experiencing serious side effects, ...

Digital Biotechnologies Inc., a new Seattle-based subsidiary of publicly traded immune medicine company Adaptive ...

Pfizer (NYSE:PFE) and GlaxoSmithKline (NYSE:GSK) are among the top drugmakers planning price increases for hundreds of ...

In new guidance, the Infectious Diseases Society of America suggested that clinicians use a scoring system to determine which ...

The federal government is no longer broadly recommending several vaccines as part of the Trump administration and Health ...

Eli Lilly is reported to be eyeing a $1 billion-plus takeover of Ventyx Biosciences that, if confirmed, suggests 2026 could ...

Chinese and Singaporean researchers have developed a defense mechanism that poisons proprietary knowledge graph data, making ...

If a patient doesn’t respond well to GLP-1s, there are other things to try. But ultimately, the medications just might not ...